Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Nasopharyngeal Carcinoma AJCC v7”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Not applicableLooking for participantsNCT06682442
What this trial is testing

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaStage III Nasopharyngeal Carcinoma AJCC v8Stage IVA Nasopharyngeal Carcinoma AJCC v8+2 more
University of California, San Francisco 66
Not applicableStudy completedNCT03314051
What this trial is testing

Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNA

Who this might be right for
Nasopharyngeal CarcinomaEBV Related Carcinoma
Taichung Veterans General Hospital 366
Large-scale testing (Phase 3)Active Not RecruitingNCT02135042
What this trial is testing

Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

Who this might be right for
Epstein-Barr Virus InfectionStage II Nasopharyngeal CarcinomaStage III Nasopharyngeal Carcinoma+2 more
NRG Oncology 685
Testing effectiveness (Phase 2)Looking for participantsNCT06064097
What this trial is testing

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Stage II Nasopharyngeal Carcinoma AJCC v8Stage III Nasopharyngeal Carcinoma AJCC v8Stage IV Nasopharyngeal Carcinoma AJCC v8
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)UnknownNCT03668730
What this trial is testing

Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 215
Large-scale testing (Phase 3)Looking for participantsNCT06239727
What this trial is testing

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 593
Testing effectiveness (Phase 2)Study completedNCT00408694
What this trial is testing

Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer

Who this might be right for
Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06532279
What this trial is testing

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+38 more
NRG Oncology
Testing effectiveness (Phase 2)Looking for participantsNCT06980038
What this trial is testing

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

Who this might be right for
Head and Neck Cutaneous Squamous Cell CarcinomaHead and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell Carcinoma+23 more
National Cancer Institute (NCI) 44
Large-scale testing (Phase 3)Study completedNCT00274937
What this trial is testing

Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer

Who this might be right for
Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7Stage I Nasopharyngeal Undifferentiated Carcinoma AJCC v7Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7+5 more
Children's Oncology Group 111
Testing effectiveness (Phase 2)WithdrawnNCT04231864
What this trial is testing

Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive Nasopharyngeal Cancer

Who this might be right for
Epstein-Barr Virus PositiveMetastatic Nasopharyngeal CarcinomaRecurrent Nasopharyngeal Carcinoma+4 more
Alain Algazi
Not applicableEnded earlyNCT03049358
What this trial is testing

Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer

Who this might be right for
Stage 0 Nasopharyngeal CarcinomaStage 0 Paranasal Sinus CancerStage I Nasopharyngeal Carcinoma+15 more
Stanford University 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03074513
What this trial is testing

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

Who this might be right for
Appendix AdenocarcinomaHuman Papillomavirus-Related Anal Squamous Cell CarcinomaHuman Papillomavirus-Related Cervical Squamous Cell Carcinoma+18 more
M.D. Anderson Cancer Center 133
Not applicableLooking for participantsNCT03010150
What this trial is testing

Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer

Who this might be right for
Carcinoma of Unknown PrimaryClinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+28 more
M.D. Anderson Cancer Center
Not applicableLooking for participantsNCT01365169
What this trial is testing

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Who this might be right for
Malignant Head and Neck NeoplasmMalignant NeoplasmMetastatic Malignant Neoplasm in the Neck+45 more
M.D. Anderson Cancer Center 590
Testing effectiveness (Phase 2)Study completedNCT02538510
What this trial is testing

Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery

Who this might be right for
Head and Neck Squamous Cell CarcinomaRecurrent Nasal Cavity and Paranasal Sinus Squamous Cell CarcinomaRecurrent Nasopharynx Carcinoma+12 more
University of Washington 50
Early research (Phase 1)Study completedNCT04870840
What this trial is testing

Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer

Who this might be right for
Locally Advanced Head and Neck Squamous Cell CarcinomaLocally Advanced Hypopharyngeal Squamous Cell CarcinomaLocally Advanced Laryngeal Squamous Cell Carcinoma+16 more
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT02339558
What this trial is testing

Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Nonkeratinizing CarcinomaRecurrent Nasopharynx CarcinomaStage III Nasopharyngeal Carcinoma AJCC v7+4 more
National Cancer Institute (NCI) 45
46
98
471